Literature DB >> 8148415

Coincidence of familial platelet glycoprotein Ib/IX deficiency (Bernard-Soulier syndrome), idiopathic autoantibody against platelet glycoprotein Ib/IX, familial appearance of antiphospholipid antibodies, and familial factor XII deficiency.

W Korte1, C Baumgartner, A Feldges, C Knöpfl, S Lutz, A Lenz, W Riesen, L Schmid.   

Abstract

The case of an 8-year-old boy with apparently homozygous Bernard-Soulier syndrome (platelet GP Ib/IX complex deficiency) and a transient idiopathic autoantibody against GP Ib/IX is described. He had been diagnosed with chronic autoimmune thrombocytopenia (due to the detection of antiplatelet autoantibodies) before Bernard-Soulier syndrome was proven. Both parents and his brother displayed intermediate deficiency of GP Ib/IX, thus indicating a heterozygote state for Bernard-Soulier syndrome. Alloimmunization as an explanation for the appearance of GP Ib/IX antiplatelet antibodies in the propositus can be excluded. A so-called pseudo Bernard-Soulier syndrome due to selective antibodies was also excluded. Flow cytometric analysis revealed residual expression of 2% GP Ib and 13% GP IX on the propositus' platelets. It seems that the propositus showed an idiopathic autoantibody against a platelet glycoprotein in which he is genetically deficient (but which is not completely lacking). Thus, in patients with untypical behavior upon therapy of "autoimmune thrombocytopenia", other differential diagnoses should also be considered even if antiplatelet antibodies are detected. In addition, all family members displayed elevated concentrations of antiphospholipid antibodies. These findings raise the question of a genetic predisposition for the development of autoantibodies. Moreover, an F. XII deficiency was found in all family members except the mother.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8148415     DOI: 10.1007/bf01715142

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  13 in total

Review 1.  Platelet membrane glycoproteins. Functional characterization and clinical applications.

Authors:  E I Peerschke
Journal:  Am J Clin Pathol       Date:  1992-10       Impact factor: 2.493

2.  [Not Available].

Authors:  J BERNARD; J P SOULIER
Journal:  Sem Hop       Date:  1948-12-28

3.  Premature stroke in a family with lupus anticoagulant and antiphospholipid antibodies.

Authors:  P M Ford; D Brunet; D P Lillicrap; S E Ford
Journal:  Stroke       Date:  1990-01       Impact factor: 7.914

4.  Monoclonal antibody--specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet-reactive antibodies.

Authors:  V Kiefel; S Santoso; M Weisheit; C Müeller-Eckhardt
Journal:  Blood       Date:  1987-12       Impact factor: 22.113

5.  Different forms of chronic childhood thrombocytopenic purpura defined by antiplatelet autoantibodies.

Authors:  P Imbach; P Tani; W Berchtold; V Blanchette; A Burek-Kozlowska; H Gerber; P Jacobs; A Newland; C Turner; L Wood
Journal:  J Pediatr       Date:  1991-04       Impact factor: 4.406

6.  Fatty acid chain is a critical epitope for antiphospholipid antibody.

Authors:  R A Levy; A E Gharavi; L R Sammaritano; L Habina; M D Lockshin
Journal:  J Clin Immunol       Date:  1990-05       Impact factor: 8.317

7.  Anticardiolipin antibodies: isotype distribution and phospholipid specificity.

Authors:  A E Gharavi; E N Harris; R A Asherson; G R Hughes
Journal:  Ann Rheum Dis       Date:  1987-01       Impact factor: 19.103

8.  Factor XII clotting activity and antigen levels in patients with thromboembolic disease.

Authors:  R von Känel; W A Wuillemin; M Furlan; B Lämmle
Journal:  Blood Coagul Fibrinolysis       Date:  1992-10       Impact factor: 1.276

9.  Biological and clinical heterogeneity of lupus and lupus-like anticoagulant in fifty-seven patients.

Authors:  M H Horellou; M H Aurousseau; M C Boffa; J Conrad; M L Wiesel; M Samama
Journal:  J Med       Date:  1987

10.  Blood antiphospholipid antibody levels are influenced by age, sex and HLA-B8,DR3 phenotype.

Authors:  A T Colucci; G Di Lorenzo; A Ingrassia; G Crescimanno; M A Modica; G Candore; C Caruso
Journal:  Exp Clin Immunogenet       Date:  1992
View more
  1 in total

1.  Congenital Combined Bleeding Disorders, a Comprehensive Study of a Large Number of Iranian Patients.

Authors:  Seyed Esmaeil Ahmadi; Mohammad Jazebi; Gholamreza Bahoush; Mohammad Reza Baghaipour; Fereydoun Ala; Shadi Tabibian
Journal:  Clin Appl Thromb Hemost       Date:  2021 Jan-Dec       Impact factor: 2.389

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.